**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 16593-81-0 |4-(2-pyridylazo)-resorcinol, monosodiu| 100.0 | unlisted |
| |m salt monohydrat | | |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully
investigated.
Potential Health Effects
Eye:
May cause eye irritation. Contact of the eye with resorcinol has
caused necrosis and corneal perforation.
Skin:
Systemic effects from skin absorption of resorcinol include:
restlessness, methemoglobinemia, convulsions, tachycardia, dyspnea
(labored breathing), and death. Resorcinol has also been reported to
cause sensitization and goiter. Resorcinol has been known to cause
hyperemia (an excess of blood in a part), itch, dermatitis, edema,
and corrosion.
Ingestion:
May cause irritation of the digestive tract. The toxicological
properties of this substance have not been fully investigated.
Inhalation:
The toxicological properties of this substance have not been fully
investigated. Inhalation of dust may cause respiratory tract
irritation.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use agent most appropriate to extinguish fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Sweep up or absorb material, then place into a suitable clean, dry,
closed container for disposal. Avoid generating dusty conditions.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low. Use
process enclosure, local exhaust ventilation, or other engineering
controls to control airborne levels.
Exposure Limits
CAS# 16593-81-0:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: brown
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: > 0 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C11H8N3O2Na.H2O
Molecular Weight: 255.21
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids, bases, acid chlorides, acid
anhydrides
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide, sodium oxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 16593-81-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-(2-pyridylazo)-resorcinol, monosodium salt monohydrat -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 16593-81-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 16593-81-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 16593-81-0 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Erbium chloride hexahydrate, 99.997%
| 10025-75-9 |
|
Inositol Hexaphosphoric Acid, 40-50 Wt% Aqueous Solution
| 83-86-3 |
|
Chlorodibromomethane, 98+%
| 124-48-1 |
|
Triethylenetetramine dihydrochloride
| 38260-01-4 |
|
2-Bromopyrimidine
| 4595-60-2 |
|
4-Aminophenol, 97.5%
| 123-30-8 |
|
p-Dithiane-2,5-diol, 95%
| 40018-26-6 |
|
4-Nitrobenzonitrile, 97%
| 619-72-7 |
|
N,N'-Octamethylenebis(dichloroacetamide), 97%
| 1477-57-2 |
|
Coumarin 175, Laser Grade
| 29197-94-2 |
|
N-Acetyl-L-Methionine, 98+%
| 65-82-7 |
|
9-Borabicyclo[3.3.1]Nonane Dimer
| 21205-91-4 |
|
(R)-(-)-10-Methyl-1(9)-octal-2-one, 98.5%
| 63975-59-7 |
|
4-Nitroaniline
| 100-01-6 |
|
4'-(4-Fluorophenyl)-acetanilide
| 398-32-3 |
|
2-Bromo-m-xylene, 98%
| 576-22-7 |
|
5-Hydroxypentanal, Tech.
| 4221-03-8 |
|
Platinum(iv) oxide hydrate, typical pt-content 79-84%
| 1314-15-4 |
|
Ethyl 6-(2-Oxocyclopentyl)-Hexanoate 96%
| 63135-03-5 |
|
Propylbenzene, 98% (GC)
| 103-65-1 |
|
Ethylene diacrylate, 70%, stabilized with 100 ppm MEHQ
| 150-76-5 |
|
4'-Aminoacetanilide, 95% (titr.)
| 122-80-5 |
|
Methyltriphenylphosphonium bromide, 98%
| 1779-49-3 |
|
4,4'-Bis(Dimethylamino)benzophenone, 98%
| 90-94-8 |
|
2-Bromomesitylene, 99%
| 576-83-0 |
|
1-Bromo-2-nitrobenzene, 98%
| 577-19-5 |
|
o-Phenylenediamine dihydrochloride
| 95-54-5 |
|
Creatine Monohydrate, 99%
| 6020-87-7 |
|
Pentabromophenol, 99%
| 608-71-9 |
|
p-Terphenyl, laser grade, 99% (uv-vis)
| 92-94-4 |
|
Adipamide
| 628-94-4 |
|
Acrylic acid, stabilized with about 200 ppm MEHQ
| 79-10-7 |
|
1-Undecanol, 98%
| 112-42-5 |
|
BBOT, scintillation grade
| 7128-64-5 |
|
Lard, Stripped
| 61789-99-9 |
|
3,4-Dihydroxy-3-Cyclobutene-1,2-Dione, 99%
| 2892-51-5 |
|
Vitamin d3,crystalline, 99+%
| 67-97-0 |
|
Dimethyl Aminoterephthalate, 99%
| 5372-81-6 |
|
1-Bromo-4-nitrobenzene, 99%
| 586-78-7 |
|
Poly TDP 2000 Antioxidant
| 63123-11-5 |
|
Triisopropylsilyl Chloride, 97%
| 13154-24-0 |
|
4-Bromopyridine Hydrochloride, 98%
| 19524-06-2 |
|
4-(2-Pyridylazo)-resorcinol, monosodium salt monohydrate, p.a.
| 16593-81-0 |
|
4-(Para-Fluorophenyl)-1,2,3,6-Tetrahydro- Pyridine Hydrochloride,
| |
|
L-(+)-glutamine
| 56-85-9 |
|
L-Arginine Hydrochloride
| 1119-34-2 |
|
L-Phenylalanine
| 63-91-2 |
|
L-Valine
| 72-18-4 |
|
L-Arginine
| 74-79-3 |
|
Lithium trisiamylborohydride 1M solution in THF
| 109-99-9 |
|
|